What should you know about TNBC treatment?

The plan starts with the extent of disease and the tumour's pathology. Some people receive drug treatment before surgery to shrink the tumour and show how it responds; others need surgery first. Radiotherapy may be advised after surgery depending on the breast operation, lymph nodes, and other findings.

Because TNBC does not have the receptors used for hormone therapy or HER2-targeted therapy, those medicines are not the usual foundation. Genetic testing and tissue features may open additional options, while response to treatment can influence what comes next.

Ask for the purpose, sequence, expected monitoring, and common side effects of each proposed treatment. Tell the team about medicines, allergies, pregnancy plans, other conditions, and any previous cancer treatment. Early reporting of fever, severe diarrhoea, breathing changes, or other concerning effects helps the team respond safely.

Read about Chemotherapy, Immunotherapy, and PARP Inhibitor Therapy before your appointment, then ask which option fits your pathology and genetic results. A second oncology opinion can be useful when the treatment choices are complex.

Use the contact instructions from your oncology unit for fever, chills, new breathlessness, chest pain, uncontrolled vomiting, severe diarrhoea, confusion, or a sudden rash. Seek emergency help for severe breathing difficulty, fainting, sudden weakness, or uncontrolled bleeding. Treatment-related symptoms can need attention even when they begin after an otherwise routine visit.

What is the goal of each treatment? Why is this sequence recommended? Do I need genetic or biomarker testing? How will response be measured? Which side effects need an urgent call? What fertility, work, and support options should I discuss?